Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Granulomatosis with Polyangiitis (Immunology) pipeline landscape. Wegener Polyangiitis is an uncommon disorder that causes inflammation ... Read More
-
Arrhythmias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Arrhythmias (Cardiovascular) pipeline landscape. An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the ... Read More
-
Myocardial Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape. Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, ... Read More
-
Restenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of ... Read More
-
Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Thromboembolism (Cardiovascular) pipeline landscape. When a blood clot (thrombus) breaks and travels in the blood, this is called a thromboembolism. Symptoms ... Read More
-
Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Pruritus (Dermatology) pipeline landscape. Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is ... Read More
-
Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 'Protein Kinase C Theta Type - Drugs In Development, 2022'; Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules ... Read More
-
Burns Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Burns (Dermatology) pipeline landscape. A burn is damage to body's tissues caused by heat, chemicals, electricity, sunlight or radiation. Symptoms include ... Read More
-
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... to the recently published report 'Cyclin Dependent Kinase 4 - Drugs In Development, 2022'; Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) pipeline Target constitutes close ... Read More
-
Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure ... Read More
-
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hypercholesterolemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes ... Read More
-
Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026
... therapeutics market by value, by molecule type, by application, by region, etc. The report provides a regional analysis of the RNAi therapeutics market, including North America (The US, Canada, and Mexico), Europe, Asia Pacific, Middle ... Read More
-
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Global Recombinant Proteins Market Size study, By Product (Antibodies, Hormones, Growth Factors, Enzyme, Cytokines, Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Other Applications), By End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028
... Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028 Global Recombinant Proteins Market is valued approximately USD 910 million in 2021 and is anticipated to grow with ... Read More
-
Antiviral Drugs Market Size By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Indication (Influenza, HIV AIDS, Hepatitis, Herpes Simplex Virus [HSV], Coronavirus Infection), By Type (Branded, Generic), By Age Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The antiviral drugs market is slated to witness notable expansion through ... Read More
-
Global RNA Analysis/ Transcriptomics Market Size study, By Product (Reagents/Consumables, Instruments, Software, Services), By Technology (Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference), By Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Contract Research Organizations), and Regional Forecasts 2022-2028
... & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Contract Research Organizations), and Regional Forecasts 2022-2028Global RNA Analysis/ Transcriptomics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy ... Read More
-
Global Stem Cell Assay Market Size study, By Type (Viability/Cytotoxicity, Isolation & Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis), By Cell Type (Adult Stem Cells, Human embryonic stem cells (hESCs)), By Product & Service (Instruments, Kits, Services), By Application (Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research), By End User (Biopharmaceutical & Biotechnology Companies, Research Institutes), and Regional Forecasts 2022-2028
... Kits, Services), By Application (Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research), By End User (Biopharmaceutical & Biotechnology Companies, Research Institutes), and Regional Forecasts 2022-2028 Global Stem Cell Assay Market is valued ... Read More
-
Global In Vitro Lung Model Market Size study, By Type (2D Models, 3D Models), By Application (Applications of 2D Models {Drug Discovery and Toxicology, 3D Model Development, Basic Research}, Applications of 3D Models {Drug Discovery and Toxicology, Physiological Research, Stem Cell Research and Regenerative Medicine}), and Regional Forecasts 2022-2028
... and Toxicology, Physiological Research, Stem Cell Research and Regenerative Medicine}), and Regional Forecasts 2022-2028Global In Vitro Lung Model Market is valued approximately USD 317.37 million in 2021 and is anticipated to grow with a healthy ... Read More
-
Acute Sinusitis Market Research Report - Forecast till 2027
... million by 2027. Sinusitis is an irritation, or expanding, of the tissue covering the sinuses. This article depicts those in danger, signs and side effects, conclusion, and medicines. The side effects of sinusitis are like ... Read More
-
United States Drug Discovery Market Forecast 2022-2028
... drug discovery and development markets with the presence of several industry players. MARKET INSIGHTS In the United States, cancer and heart disease have been leading death causes for over a decade. Also, the rising prevalence ... Read More
-
Global Drug Discovery Market Forecast 2022-2030
... the technological advancements are the primary factors propelling the market growth. MARKET INSIGHTS Drug discovery entails identifying the potential new medicines in a vast range of scientific disciplines like pharmacology, chemistry, and biology. The drug ... Read More
-
Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2026
... is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by ... Read More
-
Europe Drug Discovery Market Forecast 2022-2030
... technologies, and increased R&D expenses influence market growth in the region. MARKET INSIGHTS Italy, Russia, France, Germany, the United Kingdom, Spain, Scandinavia, and Rest of Europe are analyzed for the Europe drug discovery market growth ... Read More
-
Asia-pacific Drug Discovery Market Forecast 2022-2030
... offer lucrative research and clinical trials opportunities for pharmaceuticals and CROs. MARKET INSIGHTS Taiwan, Japan, Australia & New Zealand, India, Singapore, Indonesia, South Korea, China, and Rest of Asia-Pacific are analyzed for the Asia-Pacific drug ... Read More
-
North America Drug Discovery Market Forecast 2022-2030
... growing prioritization of several therapeutic areas like rare diseases and women’s health. REGIONAL INSIGHTS The United States and Canada are assessed for the North America drug discovery market growth analysis. In Canada, the drug discovery ... Read More
Research Assistance
